SCHEMBL26052282

SCHEMBL26052282

N#Cc1ccccc1-c1cccc(-c2nc(-c3ccc(-c4ccccc4C#N)cc3-n3c4ccccc4c4cc(-c5ccccc5)ccc43)nc(-c3ccc(-c4ccccc4C#N)cc3-n3c4ccccc4c4cc(-c5ccccc5)ccc43)n2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.38
NR3C1 P04150 1/20 0.37
GABRG2 P18507 7/20 0.37
GABRB3 P28472 7/20 0.37
GABRA1 P14867 6/20 0.37
GABRA2 P47869 4/20 0.37
GABRA5 P31644 5/20 0.36
GABRA3 P34903 5/20 0.36
CYP1A2 P05177 5/20 0.36
CYP3A4 P08684 5/20 0.36
HSD17B10 Q99714 4/20 0.36
ALDH1A1 P00352 4/20 0.36
HPGD P15428 3/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 2/20 0.35
CLK4 Q9HAZ1 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26041327 0.97 NR3C1 (0.39) TRPA1NR3C1GABRG2GABRB3GABRA1
SCHEMBL26051880 0.96 GABRA1 (0.37) TRPA1NR3C1GABRG2GABRB3GABRA1
SCHEMBL26052256 0.96 GABRA1 (0.37) TRPA1NR3C1GABRG2GABRB3GABRA1
SCHEMBL26041223 0.95 CYP1A2 (0.39) TRPA1NR3C1GABRG2GABRB3GABRA1
SCHEMBL26052194 0.95 TRPA1 (0.38) TRPA1NR3C1GABRG2GABRB3GABRA5
SCHEMBL26052257 0.94 TRPA1 (0.42) TRPA1NR3C1GABRG2GABRB3GABRA1
SCHEMBL26051881 0.93 GABRG2 (0.38) TRPA1NR3C1GABRG2GABRB3GABRA1
SCHEMBL26041326 0.93 GABRG2 (0.38) TRPA1NR3C1GABRG2GABRB3GABRA1
SCHEMBL26056021 0.93 NR3C1 (0.39) TRPA1NR3C1GABRG2GABRB3GABRA1
SCHEMBL24923987 0.93 NR3C1 (0.40) TRPA1NR3C1GABRG2GABRB3GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230276702-A1 LIGHT-EMITTING TRIAZINE DERIVATIVES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230276702-A1 LIGHT-EMITTING TRIAZINE DERIVATIVES FOR OPTOELECTRONIC DEVICES TYR, WIZ, NR2E3 TRPA1 255/4885NR3C1 1315/4885GABRG2 2413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.